API/Priceline pay shortfall review nears completion

Almost ten months since the investigation was announced A review of payroll practices at Australian Pharmaceutical Industries (API) after “historical payment errors” were flagged is nearing completion, according to the company.  The review, which was announced by Wesfarmers managing director Rob Scott in conjunction with the API parent company’s FY22 results in August 2022, came